 | Up a level |
Pesce, Gianfranco; Casiraghi, Margherita; Andratschke, Nicolaus; Gross, Markus; Zwahlen, Daniel R.; Ermis, Ekin; Herrmann, Evelyn; Vees, Hans Joerg; Castronovo, Francesco Mosé; Pupillo, Francesco; Martucci, Francesco; Canino, Paola; Porro, Elena; Deantonio, Letizia; Angrisani, Antonio; Valli, Mariacarla; Torri, Valter; Presilla, Stefano; Zilli, Thomas and Bosetti, Davide Giovanni (18 September 2023). IOSI-RT 001: a phase II single-arm, multicenter Swiss prospective trial of stereotactic irradiation of the resection cavity in patients with brain metastases from solid tumors. Strahlentherapie und Onkologie, 11(199), p. 1043. Springer
Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; ... (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of thoracic oncology, 12(4), pp. 752-762. Elsevier 10.1016/j.jtho.2016.12.017
